Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023 November 16 2023, ATLANTA– Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced a $23.6 million grant from the Bill & Melinda Gates Foundation that will fund mass production of needle-free vaccines.  The manufacturing facility will…

Read More

Echoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast

In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…

Read More

Putting the Tech in Bio & MedTech

The convergence of life and data sciences promises to dramatically accelerate the pace of innovation and drug development. Georgia is emerging as a leader in combining these fields to address some of the most challenging problems in life sciences. While generative AI is not ready to support clinical decision making, “Intelligent call centers, appointment setting,…

Read More

Life Science Nation bringing a medtech investor event to Atlanta in early 2024

In September, Life Science Nation announced “RESI South’ in partnership with a newly formed coalition of life science associations representing Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. The conference will come to Atlanta, GA, in [early] 2024. RESI South is expected to draw a crowd of over 500 bioscience and medtech entrepreneurs…

Read More

Johns Creek Named First “BioReady Community” in Georgia

As the life sciences sector in Georgia continues to grow at a rapid pace, the need for bioready sites grows. As just the second state in the country to formally adopt such a program, the BioReady Community program will allow Georgia’s municipalities to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify…

Read More

Reshaping the narrative on biopharma innovation with BIO Board Chair Dr. Ted Love

Dovetailing closely on access, advocacy, policy and innovation, BIO Board Chair and founder of Global Blood Therapeutics Dr. Ted Love discussed his mission oriented journey in the life sciences in the day’s keynote. This work continues with the need to reshape the narrative around biopharma innovation, access, cost and value. “Drug cost is not a…

Read More

Access and Advocacy: “Share the Savings”

Americans want policymakers to see lowering out-of-pocket costs for health care as a top priority. Putting pharma and its innovators who invest billions of dollars in R&D for therapies that improve outcomes and save lives in villainous crosshairs is easy to understand and politically expedient, but misguided. In 2021, West Virginia became the first state…

Read More

Access and Innovation: Georgia Bio Recommits to Industry as a new c6 & New GRA CEO Opens the 2023 Georgia Life Sciences Summit

Having recently renewed our commitment to advocating for, educating and connecting our member enterprises and stakeholders, the 2023 Georgia Life Sciences Summit by Georgia Bio brought more than 300 members of the ecosystem together in Sandy Springs on November 1st. We reconnected with friends and colleagues, made new connections, learned from academic, industry and elected…

Read More

Driven by Industry Demand, Georgia Bio Reemerges, Rededicates

A New Start Founded in 1989, Georgia Bio has been the entity around which the bioscience and medtech industry in the state, including academia, connects and advocates for its needs. Though recently latent in the visual presence to which stakeholders are accustomed, Georgia Bio has maintained, if not increased, its advocacy for the life science…

Read More